• Physical Activity in JIA Patients Deteriorates with Time, Long-term Study Finds
  • Disease Duration, Category May Help Predict Response to Enbrel in Juvenile Idiopathic Arthritis Patients
  • IMIDBio-UK Consortium Plans World’s Largest Inflammatory Disease Biobank
  • Systemic Arthritis and Prolonged Corticosteroid Use Associated with Growth Impairment in Juvenile Idiopathic Arthritis
  • Boehringer Ingelheim’s Cyltezo Receives Positive European CHMP Opinion for Chronic Inflammatory Diseases
  • Arthritis Patients Find It Hard to Explain Invisible Symptoms, Survey Shows
  • Hap & Harry’s and Kings of Leon Partner on Revelry Ale to Raise Funds for Arthritis Foundation
  • Advanced DNA Sequencing Techniques Reveal New Clues on What Triggers JIA, Study Shows
  • Arthritis Foundation Grant Funding a Study on Interplay Between Genes and Environment in Juvenile Arthritis
  • EU Approves Imraldi, a Biosimilar of Humira, for JA and Other Conditions
  • Biosimilar Erelzi Approved in Canada for Juvenile Arthritis, Other Inflammatory Diseases
  • Breastfeeding for Longer Than Four Months Reduces Risk of JIA in Children, Study Suggests